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Osteoporosis is responsible for approximately 1 . 3 to 1 . 5 
million fractures per year in the United States . The risk of 
osteoporosis increases with age, especially among 
postmenopausal women, and with lifestyle factors such as the 
use of certain drugs, heavy alcohol consumption, cigarette 
smoking, high caffeine intake, and sedentary living. Genetic 
factors that may influence susceptibility to osteoporosis 
i nclude a positive family history of the disease, or a low 
weight - for-height ratio . In some cases, race and geographic 
location may increase or decrease the risk of osteoporosis. 
Known protective factors include obesity, estrogen 
replacement therapy, weight bearing exercise, and possibly 
calcium, fluoride, and Vitamin D. Although several studies 
have examined multiple factors in single populations, few 
comparisons have been made between populations within the 
same country . 
vii 
Recent epidemiological studies have shown that the Utah 
population has lower rates of some chronic diseases than the 
national average. In this study, we used a questionnaire 
approach to relate the incidence of osteoporotic fracture to 
28 lifestyle, dietary, physical, and geographic factors in 
postmenopausal women between a Utah population and a combined 
population from North Dakota, South Dakota, and Colorado. 
Logistic regressions were used to determine the 
probability of osteoporosis for these two populations and to 
determine which factors significantly (P ~ 0. 05) increased or 
decreased the incidence of osteoporosis. The following 
factors were significantly related to the occurrence of 
osteoporosis: age, race, arthritis, cortisone, and 
fluoridated water. Dietary factors, including calcium, were 
not significantly re -~ a ted to osteoporosis in this study. The 
model successfull1 predicted the occurrence of an 
osteoporotic event in 72% of the cases. (90 pages) 
INTRODUCTION 
Osteoporosis is the most common metabolic bone disease 
in elderly women in the United States (1). Osteoporosis is 
characterized by a reduction in bone mass, microarchitectural 
deterioration of bone tissue, increased bone porosity, and a 
subsequent increased susceptibility to fracture. It is 
considered a major public health problem in the United States 
and is estimated to affect 15-20 million people (2) . 
Osteoporosis is responsible for approximately 1. 3 to 1 . 5 
million fractures in the United States alone (3, 4) . The 
estimated annual direct cost of osteoporosis is $7 billion, 
yet the inclusion of indirect costs increases the estimated 
amount to $10 billion per year (4) . In addition to medical 
costs, fractures may cause prolonged disability and premature 
death. As the elderly population grows, it is anticipated 
that osteoporosis will become even more prevalent and will 
account for a still greater proportion of the health care 
bill in the United States. 
Osteoporosis increases the risk of fracture at three 
primary sites: the hip, the vertebrae, and the distal forearm 
(Calles' fracture). Sixty-six percent of women age 65 have 
radiologic evidence of osteoporosis (5) . Hip fracture has 
the greatest degree of debilitation and is fatal in 12 to 20% 
of cases (4, 5). Approximately 250,000 hip fractures occur 
yearly, and much of the expense of osteoporosis is related to 
this type of injury (4). Twenty-five percent of the patients 
with hip fracture are confined to long - term care in a nursing 
2 
home, and 50% of hip fracture patients are not able to walk 
independently, nor live independently afterward (4, 5). The 
lifetime risk for hip fracture for white women is 
approximately 15% (4); however, women who live to be 90 years 
of age have a 33% risk of fracturing a hip (6). 
Vertebral fractures can occur spontaneously or with very 
minimal trauma, such as a cough. Riggs estimates 650,000 
vertebral fractures occur each year (4). One third of women 
age 6 5 or older experience these fractures ( 4, 7) . Vertebral 
fractures may or may not cause back pain, but once vertebrae 
are deformed, they never regain normal shape. An 
accumulation of these deformities can lead to "Dowager's 
hump," loss of stature, and to limitations in reaching, 
bending, or in other activities of daily living . Each 
complete compression fracture will cause a loss of 1 em in 
height (8). Vertebral fractures account for approximately 
160,000 physician's office visits annually (9). The 
economics, as well as disabilities attributable to vertebral 
fractures, is virtually unknown. 
Fractures of the distal radius (Colles' fractures) are 
very common among postmenopausal women, resulting in 
approximately 200,000 Colles' fractures per year (4). They 
are the most common fractures reported among white women in 
the United States before age 75, after which they are 
surpassed by hip fractures ( 8) . Colles' fractures are rarely 
fatal and cause much less disability than hip fractures. 
Less than 20% of these fractures require hospitalization, and 
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the total medical care cost is estimated to be $140 million 
annually (10). 
Epidemiological studies have revealed several risk 
factors for osteoporosis as well as several factors which are 
considered protective (e.g., 8, 11, 12, 13). These studies 
have shown that the risk of osteoporotic fractures increases 
with age, especially among postmenopausal women and among 
women who have undergone bilateral oophorectomy. The risk of 
osteoporosis can increase due to lifestyle factors, such as 
use of certain drugs, heavy alcohol consumption, cigarette 
smoking, high caffeine intake, sedentary living, and even 
possibly a high protein intake. Genetic factors that may 
influence susceptibility to osteoporosis include a positive 
family history of the disease, or a low weight-for-height 
ratio. Race and geographic location can increase risk for 
osteoporosis or be protective against it. Factors which are 
considered protective include obesity, estrogen replacement 
therapy, weight bearing exercise, and possibly calcium, 
fluoride, and Vitamin D. 
Several studies have evaluated various lifestyle risk 
factors and the incidence of fracture (14, 15, 16, 17, 18). 
Other studies have investigated the incidence of osteoporosis 
variation among race (19, 20, 21, 22) and geographic location 
' 
(23, 24, 25). A few studies have looked at the incidence of 
osteoporosis among different geographic locations within a 
country or state (26, 27, 28). Interviews and questionnaires 
have been used frequently to help assess a person's risk for 
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osteoporosis; however, they are usually used along with other 
measures of assessment, such as bone mineral density (e.g., 
1'1, 18, 29, 30, 31, 32, 33). 
A few surveys have used written questionnaires as their 
only tool of assessment. Some of these have been used to 
assess fracture risk according to various lifestyle factors 
(14, 16). A few others have used postal surveys to assess 
women's views regarding hormone replacement therapy in 
osteoporosis and to evaluate risk of falling with incidence 
of forearm fractures (34, 35) . No reported studies have used 
a written questionnaire alone to determine factors related to 
i ncidence of osteoporosis among different geographic 
locations within a country. 
Purpose and Objectives 
The purposes of this study include: 
1. To assess by mailed questionnaire, participants' 
dietary, physical, and demographic characteristics 
related to osteoporosis, 
2. To relate those characteristics to the incidence 
of osteoporotic fracture, and 
3. To assess any differences between two distinct 
female populations (Utah and non- Utah) , in the 
incidence of osteoporotic fracture, both 
geographically and according to lifestyle. 
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LITERATURE REVIEW 
As early as 1824, Astley Cooper noted the relationship 
between aging and skeletal fragility in his Treatise on 
Dislocations and on Fractures of the Joints (cited in 19) . 
Fifty years ago, Albright et al (36) suggested estrogen 
deficiency as the etiologic factor of osteoporosis in 
postmenopausal women . Today most investigators agree that 
osteoporosis is a very complex and multifactorial bone 
disorder . 
Age and Sex 
Age is probably the most powerful predictor of bone 
mass, and bone loss is considered a universal phenomenon of 
aging. Bone mass peaks by about age 35, with 90% 
accumulating before age 20 (37). Bone mass decreases after 
the fourth or fifth decade in all populations that have been 
studied (10). The most rapid rate of bone loss in women 
occurs for approximately 5 years after menopause, when there 
can be a negative calcium balance of 40-120 mg/day (38) . 
Approximately 70% of all hip fractures occur after age 65 
( 8) • 
Two distinct patterns emerge when the incidence of 
fracture is plotted as a function of age. First, fractures 
at sites which contain large amounts of trabecular bone 
increase in women shortly after menopause (4) . These are 
usually fractures of the distal forearm and vertebral 
fractures. Calles' fractures (distal forearm) continue to 
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increase until about age 65, then plateaus; vertebral 
fractures continue to rise (4, 8, 37). The second pattern is 
associated with sites containing similar amounts of cortical 
and trabecular bone. Most important is fracture of the hip, 
which increases slowly with aging and reaches a peak 
incidence between 70 and 90 years of age in both men and 
women (4, 38). 
osteoporotic fractures are more common in women than 
men. Seventy-five to 80% of hip fractures affect women and 
approximately 50% of these fractures are among women 80 years 
of age or older (8, 12). Studies from medical records show 
that hip fracture is two to three times higher in women than 
men, and incidence rates for fracture of the wrist, proximal 
humerus, and pelvis are six to eight times higher in women 
than in men (4, 24). 
Some of the reasons attributed to the higher fracture 
rate among women include a lower peak bone mass compared to 
men, the marked reduction in estrogen levels after menopause, 
and possibly a lower habitual dietary calcium intake (38). 
Geography and Race 
Incidence of osteoporosis varies considerably from one 
geographic area to another and among races. Fracture rate 
tends to be higher among whites than non-whites regardless of 
geographic location (37). It has long been known that blacks 
have greater bone mass and vertebral density, thicker bone 
cortex and fewer fractures than whites (20, 22, 39). Hip 
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fracture rates are twice as high in white American women as 
black American women (8, 22). Bollet et al (40) studied 
black and white populations in one city (Charlottesville, 
Virginia) where environmental factors should be less variable 
than in a cross-cultural study. The age-adjusted fracture 
rate for whites was approximately twice that of blacks in 
this single community study. 
The United States has the highest fracture rate (8, 41), 
and the Bantu of South Africa have the lowest recorded 
incidence of fracture (20, 37). The Moari in New Zealand 
also have a very low incidence of fracture (37) . Conversely, 
fracture rates are high among Indians in Singapore, which 
otherwise has a low incidence (19, 37). American and 
European-born Jewish women living in Jerusalem have higher 
hip fracture rates than women in that city who are native -
born Israelis or of African or Asian descent (12, 42). Smith 
(21) has shown that Puerto Rican women have fewer 
osteoporotic fractures than their American counterparts, and 
Mazess (43) found North Alaskan eskimos have a lower bone 
mineral content than white Americans. 
Lewinnek et al ( 12) compared several studies on the 
incidence of hip fracture in various countries to the 
latitude of the city studied. Lower rates of fracture 
occurred within studies in tropical cities and higher rates 
generally occurred in Northern European cities. He also 
compared the degree of industrialization, specifically motor 
vehicles in use per capita among various cities and 
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countries. A positive correlation was demonstrated between 
motor vehicles in use and fracture rate. 
Nutrients 
Several nutrients, notably calcium, have been suggested 
to influence the incidence of osteoporosis. Calcium is 
necessary for normal bone growth and for attainment of peak 
bone mass. Although the Recommended Dietary Allowance for 
calcium had been set at 800 mgjday for adults for several 
years, considerable debate persists concerning optimal 
levels. The intake of calcium during the years of bone 
mineralization appears to be related to peak bone mass. It 
is still uncertain at what age peak bone mass is attained; 
however, generally it is thought to be by age 35 and probably 
not before age 25 (44). The most current edition of the RDA 
recommends an extra calcium allowance through age 24 to 
permit more adequate mineral deposition (45). This allowance 
of 1200 mgjday had, in previous editions, only been 
recommended through age 18. 
The 1984 Consensus Committee on Osteoporosis suggested 
a calcium intake of 1500 mgjday before menopause may reduce 
the risk of osteoporosis later in life (46). Heaney et al 
(47) estimated the average calcium intake of postmenopausal 
women in the United States to be 475-575 mgjday, and 
suggested the RDA of 800 mgjday may be insufficient for many 
of these women to maintain a zero calcium balance. He 
estimated that postmenopausal women who are not estrogen 
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treated have a calcium requirement of 1540 mg/day (48). 
Calcium balance depends on dietary intake of calcium, 
intestinal absorption, and obligatory calcium loss in sweat, 
urine, and feces. The intestine becomes less efficient in 
absorption with age, especially after age 70, and coupled 
with a decline in production of 1,25-dihydroxyvitamin D, 
which aids calcium absorption, calcium requirements may 
increase with age (4, 9, 47, 49). 
Hegsted (41) has noted a sharp contrast between 
recommendations of the Consensus Conference on Osteoporosis 
and epidemiological data. The susceptible populations 
consume more calcium than those populations with low 
incidence of osteoporosis. Unfortunately, studies which 
measure bone density have shown inconsistent results from 
increasing calcium intake (eg, 8, 50, 51). This may be due 
in part to variability in dietary assessment. 
A recent review of controlled clinical trials of calcium 
supplementation has revealed some valuable insight. There 
appears to be different responses to supplementation of 
calcium in women depending on their menopausal age (52). 
During early menopause, especially the first five years, bone 
loss from the radius is attenuated, but not arrested by 
calcium supplementation (52, 53). Doses of 1000 mg/day seem 
to produce the maximal effect. The spine does not have this 
response to calcium supplementation during this early 
postmenopausal age (52). Older postmenopausal women have 
been studied less extensively than younger postmenopausal 
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women, especially women 80 years of age and older. Current 
findings in this age group of women indicate that bone loss 
from the appendicular skeleton, particularly the radius, is 
attenuated by increased calcium intake (52) . Bone loss from 
the spine may be retarded in older women who have typically 
had a low calcium diet, by increasing calcium intake to 
current RDA levels (52, 54) . Unfortunately, it is still 
inconclusive whether calcium supplementation alters hip 
density in postmenopausal women. 
While the role of dietary calcium in the etiology of 
osteoporosis remains controversial, there is growing evidence 
of its effect on peak bone mass and possible preventative 
therapeutic value (2, 38, 55, 56) Matkovic et al (26) 
studied cortical bone mass density and prevalence of hip 
fracture in two areas of Yugoslavia. The areas differed 
greatly in their consumption of calcium (450 mg/day vs 1200 
mg/day), while other variables were similar. Maximal bone 
density was significantly higher by age 20 and fracture rate 
lower among people in the high calcium district. A 
difference in bone mass of approximately 7% was responsible 
for more than a 50% difference in fracture rate. Adult bone 
status and fracture risk were established by late adolescence 
and were due to differences in peak bone mass. 
Vitamin D, as previously stated, aids in absorption of 
calcium. Vitamin D is first metabolized to 25-hydroxyvitamin 
D, or calcidiol, in the liver and then hydroxylated in the 
kidney to either 1, 25 -dihydroxyvitamin D ( 1, 25 (OH) 2 D), or to 
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24,25-dihydroxyvitamin D (24,25(0H)2 D). 1,25(0H)2 D, or 
calcitriol, is the most potent form with wide-ranging 
effects, including modulation of intestinal absorption of 
calcium and bone remodeling (57) . Various studies have been 
conducted using Vitamin D analogues in patients with 
osteoporosis. Riis (58) showed that treatment of 
osteoporosis with 24,25(0H)2 D had no prophylactic effect on 
postmenopausal bone loss. Riggs et al (59) and Gallagher et 
al (60) treated osteoporotic patients with calcitriol. 
Calcium absorption normalized in both studies, which supports 
the hypothesis that inadequate production of calcitriol is 
the primary cause of decreased calcium absorption in 
postmenopausal osteoporosis. 
Vitamin D may have a more profound effect on trabecular 
bone than on cortical bone. Bikle et al (61) infused rats 
with 1,25(0H)2 D to determine if there were varying responses 
between trabecular and cortical bone. The proximal tibia and 
shaft were examined for bone mass, calcium accumulation, and 
density distribution of bone particles. In the proximal 
tibia, vitamin D decreased calcium accumulation; however, 
there was an increase in bone mass and a shift in the 
particle distribution to more mineralized fractions. In the 
shaft there was np change in total bone mass and no decrease 
in calcium accumulation. There was, however, a 
redistribution of bone to less mineralized fractions. Bone 
resorption was not directly measured in this study, but the 
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ret result was an increase in bone mass and bone density of 
trabecular bone that was not found in cortical bone. 
The use of fluoride in the treatment of osteoporosis is 
~ill experimental. Fluoride stimulates osteoblastic 
a::tivity with a subsequent production of osteoid tissue. The 
fluoride ion is deposited in the crystal lattice of 
brdroxyapatite in place of the hydroxyl ions, resulting in a 
mi..neral phase which is more resistant to resorption ( 62) . 
Ruoride doses of 1 ppm do not appear to have an effect on 
hcidence of fracture; however, Iskrant ( 63) found that 
rrortality from falls in elderly white women is lower at 
htakes of 4 ppm or greater. In 1966, an epidemiological 
s: udy of two populations in North Dakota showed a high 
f uoride intake ( 4 to 5 . 8 ppm) reduced the number of 
rnteoporotic fractures (28) . An autopsy study showed 
c1ncellous bone strength was greater in immobilized women who 
crank fluoridated water than those whose water was not 
ftuoridated (64). More recent studies have indicated that 
f luoride treatment 
t1erapeutic window 
f::-acture remains 
of osteoporosis has 
(3, 65). Its effect 
controversial and is 
a very narrow 
on incidence of 
probably dose 
d~pendent. Riggs (4) notes that fluoridic bone has increased 
c::-ystallinity, but also has decreased elasticity, and, 
t1erefore, may be structurally abnormal with decreased bone 
s:rength. A recent study failed to demonstrate a decrease in 
v~rtebral fracture rate after 4 years of treatment with 75 mg 
o: sodium fluoride per day, in spite of an increase in 
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trabecular bone mass of the spine (66). Pak (65) states that 
fluoride can protect against vertebral fracture, but not 
alone or in high dosages. He recommends that calcium be 
given with a slow release form of sodium fluoride to allow 
for adequate mineralization of bone and minimum risk for 
fracture. 
Experimental increases in protein increase urinary 
calcium excretion and may have adverse effects on calcium 
balance. Hegsted (41) suggested that a high osmotic load on 
the kidney, due to the high protein diets of affluent western 
societies, might eventually impair the kidney's ability to 
regulate calcitriol levels. Epidemiological data show hip 
fractures and protein are positively related (41) . Mazess 
(43) has shown North Alaskan Eskimos have lower bone mineral 
content than United States whites and suggested their high 
protein diet (200-400 g/day) as a contributing factor. 
Physical Activity and Body Build 
Decreased physical activity often accompanies the aging 
process and has been implicated as a risk factor in 
osteoporosis. Prolonged inactivity causes atrophy in muscle 
and bone tissue, and immobilization is known to reduce bone 
mineral content (67). Athletes are known to have greater 
bone densities than non-athletes. Brewer et al (32) compared 
the skeletal status of marathon runners and sedentary 
premenopausal women, 30-49 years of age. Bone mineral 
content and density were greater in the distal radius of the 
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marathon runners than the sedentary women. Pocock et al (68) 
studied the relationship between physical fitness and bone 
mass in the femoral neck, lumbar spine, and forearm in 
eighty- four pre and postmenopausal women. In the 
postmenopausal women, fitness was the only significant 
predictor of femoral neck bone density, whereas weight and 
fitness were predictors in lumbar spine density. Increased 
fitness may increase bone density at clinically important 
fracture sites in osteoporosis. Heinrich et al (33) compared 
bone mineral content at four skeletal sites among young 
female adults who regularly performed either weight lifting, 
running, swimming, or were inactive. Body builders had 
greater bone mineral content than runners, swimmers, or 
controls. Due to the results of their study, they suggested 
that weight training may provide more stimulus for increasing 
bone mineral content than nonresistance endurance exercise. 
Thin women have less cortical bone mass and are at 
greater risk for osteoporosis than obese women ( 8) . Williams 
et al (69) found . the risk of hip fracture was elevated in 
thin postmenopausal women, and Hemenway et al (14) found the 
combination of thinness and alcohol consumption of more than 
15 g/day substantially increased the incidence of fracture. 
Obesity is considered protective against osteoporosis. Most 
of the estrogen produced postmenopausally is from the 
conversion of androstenedione to estrone and much of this 
conversion takes place in adipose tissue. Obese women are 
therefore likely to produce more estrone than thin women ( 8) . 
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In addition, greater body weight may be associated with 
greater peak bone mass in early adulthood. 
Alcohol and Smoking 
The relation between lifestyle variables such as alcohol 
and smoking and risk for fracture is not well understood. 
Daniell (70) noted that women who were smokers lost an 
average rate of 1.02% of cortical bone per postmenopausal 
year compared with 0.69% per postmenopausal year for 
nonsmokers. The age of menopause was earlier for smokers 
than for nonsmokers ( 4 7. 6 vs 49 .1) in this study. He 
concludes that the lower frequency of obesity in the women 
who smoked contributed significantly to the greater loss of 
cortical bone than was seen in the nonsmoking subjects 
studied. 
In a study conducted by Williams et al ( 69) 1 
postmenopausal women were interviewed to determine which 
characteristics influence the occurrence of fracture. 
Subjects were women ages 50-74 who had sustained either hip 
or forearm fractures. Estrogen use, height and weight 
status, and smoking history were evaluated. The risk of hip 
fracture was greater among thin women who smoked, especially 
if they did not use estrogen. Smoking did not increase the 
risk of forearm fractures in estrogen users, but among 
nonusers of estrogen, smoking did increase the risk, 
especially in those who were thin. 
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Conversely, a study on fracture and lifestyle 
ch~racteristics by Hemenway et al (14) found that smoking was 
not a risk factor for hip or forearm fracture. This study, 
involving registered nurses, used a mailed questionnaire to 
as3ess fracture risk. A limitation of the survey was the age 
grJup of the women surveyed. Only 37% were in an age group 
th~t could be considered near menopause or postmenopausal. 
Th: population studied may have been too young to determine 
th: effects of smoking on fracture risk. 
Decreased bone mass has been noted in patients who abuse 
al.:ohol (71, 72). Several explanations have been proposed to 
ac.:ount for this. These include nutritional deficiencies of 
calcium and Vitamin D, malabsorption of calcium and Vitamin 
D secondary to pancreatic or liver disease, abnormalities in 
me:abolism of Vitamin D due to cirrhosis of the liver, 
ab:1ormal parathyroid function or secretion induced by ethanol 
directly or indirectly, or a toxic effect of ethanol on 
caLcium absorption. There is also a possible effect of 
et1anol on bone remodeling (71). 
ca:feine and Drugs 
Caffeine has been a reported risk factor for 
os:eoporosis, particularly because of its effect on calcium 
ex~retion. The average intake of caffeine in the American 
PO?Ulation is about 250 mg/day. Massey and Wise (73) and 
Ma3sey and Berg (74) studied the effect of dietary caffeine 
onurinary excretion of several nutrients including calcium. 
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Subjects fasted for 10 hours prior to receiving 0, 150, or 
3 00 mg caffeine · in beverage form. Total 3- hour urinary 
excretion of calcium increased significantly after caffeine 
intake. Urinary concentrations of calcium nearly doubled 
after ingestion of the higher (300 mg) caffeine dose . 
Heaney ~nd Recker (75) studied the effects of different 
levels of nitrogen, phosphorus, and caffeine on calcium 
balance in premenopausal women. Caffeine consumption 
correlated with a decreased calcium balance in their subjects 
by increasing both urinary and intestinal calcium losses . 
Chronic use of certain drugs may increase bone loss and 
predispose their users to fracture. These include certain 
diuretics, heparin, antacids containing aluminum, excessive 
doses of thyroid hormone, and corticosteroids. Of these, 
corticosteroids have been the best documented. Although the 
anti-inflammatory and immunosuppressive effects of 
glucocorticoids is extremely therapeutic, adverse effects 
include the development of osteopenia with an increased 
propensity to bone fracture (76) . There are approximately 
five million individuals in the United States who take 
steroid medication, and many of these are over age 65 (76, 
77) . These people would already be prone to osteoporosis, as 
well as to age-dependent decreases in bone mass and 
intestinal calcium absorption. Additional glucosteroid 
effects on the skeleton in this age group are obviously 
undesirable. A study done by Reid and Heap (78) addressed 
the impact of glucocorticoid therapy on vertebral mineral 
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density. There was a significant relationship not only in 
the duration of steroid treatment and vertebral mineral 
density but also in the total cumulative steroid dose. The 
authors cautioned that effort should be made to minimize 
dosage and duration when using glucocorticoid therapy. 
Reproductive History and Heredity 
Childbearing and breastfeeding have also been studied in 
respect to changes in bone mass and fracture risk. Calcium 
demands during pregnancy and breastfeeding are accompanied by 
changes in levels of Vitamin D, calcitonin, and parathyroid 
hormone. These changes lead to alterations in bone mineral 
metabolism such as increased gastrointestinal absorption and 
increased renal conservation of calcium. Some studies 
indicate pregnancy and breastfeeding are associated with a 
decreased risk of postmenopausal hip fracture or bone loss 
(77, 30). Wyshak (77) collected data from nursing home 
records to examine the relationship between hip fracture and 
reproductive history. She found a sharp decline in incidence 
of hip fracture among women of high parity of four or more 
living children. In contrast, Alderman et al (29) did not 
find any significant relationship among parity, 
breastfeeding, and risk of hip or forearm fracture. Aloia et 
al (30) examined the relationship of various factors to bone 
mass in early postmenopausal women. Breastfeeding and 
pregnancy were associated in this study to higher bone mass. 
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There is a definite direct relationship between estrogen 
loss and osteoporosis . Bone loss occurs whenever estrogen 
levels are reduced, whether by natural menopause or by 
oophorectomy (79) . Evidence exists that trabecular bone loss 
may begin as estradiol production rates start to decline, 
even prior to cessation of menses (80) . Many studies have 
shown that estrogen replacement therapy prevents or greatly 
retards bone loss in postmenopausal women as long as the 
therapy is continued (81, 82, 83) . The recommended dose is 
0 . 625 mg of conjugated estrogen; adding a progestogen does 
not interfere with skeletal response to estrogen and appears 
to decrease the risk of unopposed estrogen therapy and 
endometrial cancer (3) . Estrogen therapy given early in 
menopause for at least five years reduces hip and Colles' 
fractures by approximately 50%, and vertebral fractures by 
90% (3) . However, the effect of estrogen is reversible . 
When therapy stops, the accelerated phase of bone loss will 
occur again (77) . This does not mean the benefits of 
estrogen are lost . If, for example, a woman uses estrogen 
therapy for 10 years, her bone mass "age" will be at least 10 
years younger than her actual age when she discontinues the 
therapy (77) . 
Various studies have shown a relationship between 
heredity and bone mass. Genetic studies of twins show strong 
associations between bone mineral content and bone density 
(55, 84). Mother-daughter pairs have also been studied, and 
frequently a significant relation between bone mass and 
genetics has been noted (55, 85) . 
suggest that inheritance of bone 
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Lutz and Tesar ( 85) 
mass may have two 
components, one which influences development of peak bone 
mass and one related to loss of bone at menopause. Pollitzer 
and Anderson (55) reviewed ethnic and genetic factors in bone 
mass and indicated that the bone mass accumulated by age 20 
is highly associated with maternal bone mass, but beyond 
menopause other factors of environmental nature seem to 
dominate. 
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METHODOLOGY 
Subject Selection and Rationale 
The population sample was chosen from female 
postmenopausal subjects in Utah, and three Great Plain 
states, North Dakota, South Dakota, and Colorado (Non-Utah). 
This allowed for subjects that carne from two distinct 
geographical regions of the United States, and from 
populations that differ in their predominate religious 
preference. 
Some studies have indicated that lifestyles associated 
with certain religious preferences lend themselves to lower 
rates of some chronic diseases (86, 87, 88). The majority of 
Utah's population (70%) are members of the Church of Jesus 
Christ of Latter-Day Saints (Mormons) . The Mormon church 
teaches abstinence from alcohol, caffeine, and smoking. It 
promotes a healthy lifestyle, including a prudent diet and 
regular exercise. Mormons typically have large families, 
giving Utah the highest birth rate in the United States. All 
o'f these factors have been implicated in osteoporosis and, 
therefore, may give many Utah women added protection against 
bone loss. 
Recent surveys. have shown that Utah has lower rates of 
some chronic diseases than the national average. Morbidity 
and Mortality Weekly Report ( 89) shows Utah to have the third 
lowest mortality rate from coronary heart disease ·in the 
United States. Some behavioral risk factors associated with 
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many diseases are less prevalent in Utah than other states 
s ·1rveyed. These factors include obesity, sedentary 
lifestyle, smoking, and alcohol abuse (90). Utah women, 
iJcluding those who are postmenopausal, have a higher calcium 
iJtake than average when compared to the USDA Household Food 
Consumption Survey (91) . 
Utah's population is 1,461,037 and is composed of 94% 
Caucasian and approximately 4% Chicano. Four - fifths of the 
population of Utah live in urban areas. Utah's water supply 
is primarily non-fluoridated . 
Colorado has a population of 2,889,964 of which 
approximately 89% is Caucasian . The remaining population is 
primarily Black, Japanese, and American Indian. Eighty 
percent of the population are in urban areas. The 
predominate religions are Roman Catholic, Methodist, and 
Baptist. 
North Dakota's population is 652,717, and it is still a 
rural state with urban residents in only a few metropolitan 
areas. Its population is primarily Caucasian with about 5% 
of the remaining population being American Indian, Black and 
Asian. The predominate religions are Lutheran and Roman 
Catholic. 
South Dakota has a population of 690,768 and is 
3.pproximately 54% rural. Its population is 6% American 
Indian, 3% Black, and the rest is mostly Caucasian. 
Lutheran, Roman Catholic, Methodist, and Presbyterian are the 
nost common religious faiths. 
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The non- Utah states more commonly have fluoridated water 
with some regions in Colorado and North Dakota having greater 
than 4 ppm. 
Questionnaire Design and Implementation 
A written questionnaire was designed and implemented 
using standard techniques (92, 93). Special attention was 
given in developing the questionnaire for the target 
population which was an elderly group of postmenopausal 
women. This included the design of the cover page, large 
print throughout the questionnaire, and ease of completion. 
The questionnaire is found in Appendix A. Questions 
pertaining to lifestyle, nutrient intake, medical history, 
and demographics were asked. 
Lifestyle factors included the evidence of weight 
bearing exercise, amount of smoking, and the ingestion of 
caffeine and alcohol. Nutrient intake focused primarily on 
calcium content of the diet; however, use of vitamin 
supplements was also evaluated. 
information regarding family 
The medical history gathered 
history of osteoporosis, 
incidence of fracture of the hip, vertebrae or wrist, use of 
medications, evidence of chronic disease, surgeries such as 
hysterectomy, use of estrogens, and age of menopause. 
Demographic data included the subject's age, height, weight, 
number of children, race, religious preference, residence, 
and fluoridation .of the water supply. 
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The questionnaire was pretested on a small sample of 
postmenopausal women as a portion of a separate study (pers. 
comm . , Dr. G. Lauritzen and Dr . D. Hendricks, Utah State 
University, Logan). This study examined risk factors 
relating to osteoporosis and also required the participants 
to undergo Computed Tomography at Logan Regional Hospital. 
Participants had no difficulty in completing the 
questionnaire, and · it appeared to be ready for use on a 
larger scale . 
The questionnaire was distributed to 600, 200, 200, and 
200 postmenopausal women in Utah, North Dakota, South Dakota, 
and Colorado, respectively . The surveys were mailed i n bulk 
to Registered Dietitians working in the Division of Aging and 
Adult Services in each of the four states. The dietitians 
then distributed the surveys to area managers of senior 
citizen centers throughout their state . The surveys were 
distributed more heavily in urban areas; however, both urban 
and rural areas were covered. Women at the senior citizen 
centers were asked to fill out the questionnaire. Each 
questionnaire was coded with a four digit identification 
number in the upper right hand corner. The first digit 
corresponds to the state to which it was sent . A cover 
letter was attached to each questionnaire explaining the 
purpose of the survey and requesting the assistance of each 
participant . A self-addressed stamped envelope was attached 
to each questionnaire for return of the questionnaire. A 
follow-up letter was mailed to the. previously mentioned 
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dietitians in each state for distribution to the area 
managers of the senior citizen centers. These served as a 
thank-you to all the participants and a reminder to non-
responders to return their questionnai~es. Due to limited 
funding for this research project, a second mailout was not 
attempted. 
Upon return of the questionnaires, data were coded using 
standard categorical coding procedures. A copy of the codes 
is included in Appendix B. When participants did not respond 
to any given question, they were placed in a no response 
category. 
For the purposes of this study, participants were 
classified as osteoporotic or non - osteoporotic . A 
participant was defined as having osteoporosis when at least 
one of the following criteria was met: 
1. A participant was diagnosed by a physician as 
having osteoporosis (Question #1 = yes) . 
2. A participant had a fracture in any of the three 
major osteoporotic sites (wrist, hip, or spine), 
and the fracture occurred at or after the age of 
menopause (Question #3 = yes, and Question #22 = 
yes). 
3. A participant had a fracture in any of the three 
major osteoporotic sites and did not respond to 
the question concerning age of menopause (Question 
#3 = yes, and Question #22 = no response), yet the 
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fracture occurred at or greater than age 55 
(Question #3a ~ 55). 
The average age of menopause in the United States is 51. 
A women was defined as postmenopausal if she recorded her age 
as 55 or greater, allowing a reasonable margin for individual 
variation. 
If a participant was not diagnosed by a physician to 
have osteoporosis, and age of menopause as well as current 
age was not recorded by the participant (Questions #22 and 
25), then osteoporosis status was put in a no response 
category. 
If questionnaires were not adequately completed, they 
were rejected from the sample. For example, if the 
participant failed to answer critical questions to the study, 
particularly questions regarding medical history and 
demographic information, they were rejected. If a 
participant failed to give only selected information, such as 
current weight, this was simply coded as a no response 
category. 
Calcium intake was calculated for each participant in mg 
calcium/month from the food frequency information found in 
the questionnaire (Questions 5-11) . Calcium content for the 
serving size given for each food in the questionnaire was 
calculated from food tables in USDA Handbook #8- Composition 
of Foods. Calcium content of milk was calculated using the 
value for 2 %milk (297 mgjcup). The calcium contents of 
yogurt (311 mg/8 ounces), hard cheese (200 mgjounce), cottage 
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cheese (73 mg/0.5 cup), ice cream and frozen yogurt (88 
mg/0. 5 cup), and bread (23 mg/slice) were calculated by 
averaging their various respective types. If the participant 
answered "never" to any of the questions · regarding 
consumption of a high calcium food, the calcium intake for 
that food was 0 mg/month. If the participant answered 
"monthly" (1-3 days/month), "weekly" (1-4 days/week), or 
"daily" (5-7 days/week) to any of the food consumption 
questions, an average of 2 days/month, 8 days/month, or 28 
days/month was calculated for monthly calcium intake of that 
food. 
Caffeine intake was calculated for each participant in 
mg caffeine/month. Caffeine content of coffee and tea was 
calculated as rng/cup and as mg/12 ounces for cola . 
Alcohol servings per month were also calculated for each 
participant. One serving equals 12 ounces of beer, 4 ounces 
of wine, or 1 ounce of hard liquor . 
Participants were asked to indicate weight bearing 
exercise in which they were engaged (Question #24) . They 
recorded the number of times weekly or monthly they 
participated in each activity and also the typical duration 
(minutes/day) . From this information, the participant's 
total minutes/month of weight bearing activity were 
calculated. 
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Statistical Analysis 
Significant factors related to the occurrence of 
osteoporosis were determined using a hierarchical log-linear 
modeling approach that led to a final logit model (94) . The 
occurrence of osteoporosis was the dependent factor while 
demographic, lifestyle, and geographic parameters were the 
independent factors in the logit model. Significant logits 
were transformed to provide a probability of osteoporosis . 
Descriptive variables that were measured as continuous data 
(eg, height, height-loss) were tested between the two groups 
using an analysis of variance . 
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RESULTS 
Out of a total of 1200 surveys, 723 were returned, 
giving a response rate of 60%. Depending on the variable 
examined, and the analysis method, the total useable number 
of respondents varied from 584 to 655. Caucasian was the 
predominant race in Utah and non-Utah respondents (92% and 
97% respectively), with the remainder being divided among 
Asians and Blacks in similar proportions to those found in 
the general population. 
Differences in the predominant religious preference 
between the Utah and non-Utah respondents were anticipated . 
The religious preference of Utah respondents was 67% IJDS, 16% 
Protestant, and the remainder divided among other religions, 
or no religious preference. The religious preference of non-
Utah respondents ·was 67% Protestant, 25% Catholic, and the 
remainder divided among other religions, or no religious 
preference. 
There was a slight, but significant difference in age 
between osteoporotic and non-osteoporotic (P < 0.01, 73.4 vs . 
70.6 years) and between Utah and non-Utah (P = 0.03, 70.6 vs . 
72.6) respondents. There was no significant difference in 
weight between osteoporotic and non-osteoporotic (P = 0.43) 
and between Utah and non-Utah (P = 0.27) respondents (Figure 
1) . There was also no significant difference in height 
between osteoporotic and non- osteoporotic (P = 0. 74) and 
between Utah and non-Utah (P = 0.88) respondents (Figure 2). 
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FIG 2 . Mean (± 1 S.E.) height of respondents with and without 
osteoporosis and height loss of respondents from age 21 to 
present with and without osteoporosis. 
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Participants were asked to record their current height, 
as well as their height at age 21. Height loss from early 
adulthood to current postmenopausal age was calculated. 
There was a significant difference in height loss between the 
two osteoporosis groups (P < 0.01); however, the two state 
groups did not differ (P = 0.67). Height loss in the non-
osteoporotic group was 0.47 inches, while the height loss in 
the osteoporotic group was 0.92 inches (Figure 2). 
Caffeine intake (mg/month) was calculated for Utah and 
non-Utah respondents with and without osteoporosis. Mean 
intake of caffeine in non-Utah respondents without 
osteoporosis was 434 mg/day, while non-Utah respondents with 
osteoporosis was 389 mg/day. As anticipated, the Utah 
respondents had a lower mean caffeine intake. The Utah group 
without osteoporosis had a mean caffeine intake of 206 
mg/day, and the osteoporotic group had a mean intake of 145 
mg/day. There was a significant difference between caffeine 
intake and various religions (P < 0.01). Catholics had a 
greater caffeine intake than all other religions, while 
Mormons had the lowest caffeine intake. Other religions were 
intermediate in their caffeine intake. 
There was no significant difference in dietary calcium 
intake between Utah and non- Utah (P = 0. 34, 1014 vs 1010 
mg/day) and between osteoporotic and non-osteoporotic (P = 
0.39, 1047 vs 999 mg/day) respondents. There was also no 
significant difference in calcium intake between various 
races (P = 0.27). 
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The total number of children breastfed and the duration 
of breastfeeding for each participant was calculated . There 
was a marginal difference in number of children breastfed 
between osteoporotic and non - osteoporotic participants (P = 
0.052, 1.6 vs 1 . 9 children) . 
There was a significant difference in alcohol servings 
between Utah and non - Utah respondents (P < 0 . 01, 1.13 vs 
0 . 81) and between religious preferences (P < 0.01) . 
Respondents who indicated their preference as "other" 
consumed more alcohol than those who were LDS, and those who 
indicated no religious preference consumed more than those 
who were LDS. 
For exercise, there was a significant interaction 
between osteoporosis and state (P = 0. 04) . For the Utah 
population, the osteoporotic group exercised more than the 
non-osteoporotic group (113 vs 93 minutes/month) , whereas the 
reverse was true for the non - Utah population ( 63 vs 83 
minutes/month) . 
The probability of 
osteoporosis was related 
postmenopausal 
significantly to 
women having 
the following 
factors: arthritis, age, cortisone, fluoridated water, and 
race (Table 1) . The model successfully predicted the 
occurrence of an osteoporotic event in 72% of the cases . A 
woman between the ages of 50-59 has approximately a 7% 
probability of having osteoporosis. This increases to about 
18% by the eighth decade of life, or approximately 2.5-fold 
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Table 1. 
The best-fit legit model for the occurrence of osteoporosis 
(Oy = osteoporotic; ON non-osteoporotic) and the maximum 
likelihood estimates for the significant explanatory 
variables. 
0 log(___!") = -6.64 + 0.37F + 1.13C + 1.24A + 0.04AC - 0 . 56R 
ON 
Explanatory Parameter Chi-square P > Chi-square 
Variable Estimate 
Intercept -6.64 43.57 0 . 0001 
Fluoride in 
Water (F) 0.37 8 . 89 0 . 0029 
Cortisone (C) 1.13 12 . 76 0 . 0004 
Arthritis (A) 1.24 35.13 0 . 0001 
Age Class (AC) 0.04 11.96 0.0005 
Race (R) -0.56 3.93 0.0474 
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increase risk of osteoporosis (Figure 3). If a woman between 
the ages of 50-5~ also has arthritis, her risk for having 
osteoporosis increases to 20%. By the time a woman is 80 
years old and has arthritis, her risk of having osteoporosis 
increases to 43%. Adding cortisone to the previous risk 
factors of age and arthritis nearly doubles the probability 
of having osteoporosis in each age category . Adding fluoride 
to the model does not cause a dramatic increase in the 
probability of having osteoporosis; however, there is a 7% 
increase by age 80 . 
Geographic region (Utah vs . non - Utah) was not a 
significant explanatory variable in the logistic regression . 
Therefore, the region in which people lived did not 
contribute to the likelihood of having osteoporosis. Dietary 
factors, including dietary and supplemental calcium, were not 
significantly related to osteoporosis in this study . 
Osteoporotic risk by race is illustrated in Figure 4. 
As age class increases among Caucasian as well as Asian 
races, the probability of having osteoporosis increases. The 
Asian population studied was small (n = 23) in comparison to 
the Caucasian population. In the age class of 50-59 years 
among Caucasians, there is approximately a 7% probability of 
having osteoporosis. This increases to 18% in the eighth 
decade of life, or again, approximately a 2.5-fold increase 
risk of having osteoporosis. 
is only a 1% probability 
For Asians, at ages 60-69 there 
of having osteoporosis, which 
increases to a 2% probability by age 80. 
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FIG 3. The probability of having osteoporosis with increasing 
age and with the cumulative effect of three risk factors 
(arthritis, cortisone, and fluoride). Columns represented by 
the letter I indicate insufficient numbers of individuals to 
estimate the probability of that category. 
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DISCUSSION 
Osteoporosis is a disease primarily of the elderly and 
is rarely found in women prior to menopause. For 
osteoporosis to be present in a younger person, there must be 
unusual circumstances such as surgical menopause with no 
estrogen replacement therapy, Cushing's syndrome, excessive 
exposure to glucocorticoids, or bone loss from exercise-
induced amenorrhea (7, 95). Age was the only factor 
significant in both analysis of variance and logistic 
regression. Because age-related bone loss is universal, much 
attention has been focused on attaining optimum peak bone 
mass during youth. One author stated that "osteoporosis is 
a pediatric disorder that presents to the geriatrician" (80, 
p. 45). Age-related bone loss begins around age 40 for 
cortical bone and 5-10 years earlier for trabecular bone 
loss; this continues into extreme old age (4). Age is such 
a powerful predictor of bone mass that bone density (lumbar 
spine or femoral neck) can be predicted with a standard 
deviation of only 10%, simply from a woman's age (4). 
With increasing age, there is usually an increased 
propensity to fall. This may be due to a number of reasons 
including failing vision, arthritis and other diseases, 
drugs, and slm.,rer reflexes. Most authorities consider 
prevention of osteoporosis in terms of exercise, adequate 
calcium intake, and estrogen replacement therapy. Innovative 
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strategies for preventing falls in our increasing elderly 
population should also become part of prevention planning . 
Both Caucasian and Asian races have been cited by 
numerous authors as risk factors for osteoporosis (eg, 3, 7, 
8, 55) . Caucasians have the greatest risk of all races; 
however, it has been noted that Asians have less cortical 
bone mass than whites ( 9 6) . Nordin (23) did a worldwide 
survey of osteoporosis and found a significant relationship 
between osteoporotic radiographs of the spine and low calcium 
intake. In Japan, where calcium intake is low, he found 
spinal osteoporosis to be very common. However, hip 
fractures were much less common and only constituted 0 .1 % of 
all admissions to the university hospital in Tokyo during a 
six-year period. The hip fracture rate per 100,000 women for 
the United States is 295.0, whereas for Hong Kong it is 72 . 4, 
and for the Chinese in Singapore, it is 50.3 (55). When 
dealing with race as a risk factor, environmental and dietary 
factors can be confounding. Although the Japanese and other 
Asian populations have lower incidence of hip fracture than 
Caucasian populations, lifestyle factors must be accounted 
for. Traditional Japanese women live close to the floor and 
frequently squat, rise, and sit again; they generally do not 
work outside the home and spend more time in traditional work 
within the home. The lower hip fracture rate is thought to 
result from the increased sitting and rising activities and 
the high incidence of vertebral osteoporosis from low calcium 
intake (55) . As seen in Figure 4, Caucasians had a much 
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greater probability of having osteoporosis than did Asians in 
our survey. There was a desire in this study to evaluate 
more racial groups; however, the random sampling was 92-97% 
Caucasian with only 4% Asian. The Asian group was found 
primarily in one senior citizen center in Utah. Although the 
proportions of the race classifications are similar to those 
i n the general public in these states, caution in 
i nterpreting these results must be used due to the small 
sample size of Asians. 
Glucocorticoid use is associated with decreased 
i ntestinal calcium absorption and increased urinary calcium 
loss, diminished bone formation, and increased bone 
resorption ( 78, 97) . Long- term use of glucocorticoids leads 
to osteoporosis. Chronic corticosteroid use is mentioned as 
a risk factor by numerous investigators (5, 7, 8, 78, 80). 
The results in this study confirm those of several authors 
who have demonstrated an increased risk of osteoporosis with 
the use of corticosteroids (78, 98, 99). Arthritis is also 
cited as a risk factor for osteoporosis by some investigators 
(e . g . 7, 8, 80). However, the precise mechanism involved is 
not known. Often people suffering from arthritis have 
limited ability to exercise and therefore have a sedentary 
lifestyle which is associated with bone loss. The data from 
the National Health and Nutrition Examination Survey (NHANES 
1) shows a high prevalence of musculoskeletal impairments, 
i ncluding all types of arthritis, among elderly persons 
(100). The survey also found rheumatoid arthritis to be more 
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prevalent among women and among Whites compared to non-
Whites. Cortisone is often prescribed for arthritis. 
Therefore, it is reasonable to suggest a relationship among 
women in their incidence of arthritis, use of cortisone , 
race, and age. All of these risk factors were significant in 
our survey. 
Although fluoride did not add as much to the model as 
other factors, it was still significant. 
generally thought of as therapeutic 
Since fluoride is 
treatment for 
osteoporosis, one might conclude the results from this study 
are contrary to existing literature . However, recent 
research has mixed reviews of the therapeutic role fluoride 
plays in osteoporosis. Fluori de has been evaluated more 
widely than any other formation-stimulating regimen , yet its 
use in treatment of osteoporosis is very controversial in the 
United States and has not yet received United States Food and 
Drug Administration approval for use in osteoporosis . Pak 
(65) concluded there are several problems related to fluoride 
treatment for osteoporosis. Its narrow therapeutic window 
has made it difficult to maintain appropriate blood fluoride 
levels without exceeding the toxic threshold. The bone 
created may be mechanically defective, and fluoride in high 
concentrations may actually be toxic to osteoblasts. Another 
problem is that 25-30% of patients may not respond to 
fluoride treatment. In this survey, we assessed only whether 
the participant drank fluoridated water or not. Levels of 
fluoridation in the water supplies were not assessed; 
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however, we do know that some areas in Colorado and North 
Dakota have high fluoride content and that fluoridation in 
Utah is nearly nonexistent. Studies evaluating incidence of 
fracture and level of fluoridation in the water supply have 
had varying results. Leone et al (101) and Bernstein et al 
(28) both found decreased incidence of vertebral fracture in 
areas of high natural fluoridation compared to regions of low 
fluoridation. A more recent study found similar results in 
Finland, comparing low and high levels of fluoridation (102) . 
Femoral neck fractures had a lower prevalence in high 
fluoride areas compared to low fluoride areas. However, 
Sowers et al (103) compared regions of high and low 
fluoridation and reported no difference in fracture rate. 
Likewise, the National Health Interview surveys in 1973 did 
not find a relationship between fluoride content of drinking 
water and incidence of hip fracture ( 104) . The role of 
fluoride in regard to osteoporosis remains an area of further 
study and debate. 
Vertebral fractures in osteoporosis include a 
combination of compression (collapse of the entire vertebral 
body), concavity (collapse of the endplates), or wedging 
(relative loss of anterior height) . These can all reflect 
fracture ( 13) . Definition of a new vertebral fracture 
requires a 15% reduction in vertebral height; however, 
changes in shape cannot be assessed in a survey of fracture 
occurrence such as ours (13). It is thought that by age SO, 
most white women have had a least one partial vertebral 
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deformity (8). Trabecular bone is concentrated in the 
vertebrae and is much more active metabolically and, 
therefore, more responsive to hormonal changes. In women, 
the accelerated bone loss due to estrogen deficiency at 
menopause results in a disproportionate loss of trabecular 
bone from the vertebrae . Loss of height is one of the 
symptoms of vertebral fracture ( 4) . Our results show q. 
greater height loss from early adulthood to old age in the 
osteoporotic group than the non-osteoporotic group. The loss 
of height in both groups was determined from the respondents ' 
estimate of current height as well as height in their youth . 
A preferred method of estimating height loss would be actual 
measurements of participants; however, we believe our resul ts 
reflect the presence of osteoporosis . 
Although there was a significant difference in caffeine 
intake among religions, caffeine was not a significant 
factor in the probability of having osteoporosis i n this 
study. Utah has lower mortality rates from some chronic 
diseases, and the predominance of the Mormon religion and the 
lifestyle it entails may contribute to this. However , in 
this case there was no protection from the occurrence of 
osteoporosis due to a lower intake of caffeine. 
There was a marginal difference in the number of 
children breastfed between the osteoporotic respondents and 
the non - osteoporotic respondents, however,it was not part of 
the log linear model. When analysis of variance is used, 
there is a trend that those who were non-osteoporotic 
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breastfed more children than those with osteoporosis. These 
results are consistent with several other studies which 
indicate that . breastfeeding may be a protective factor (11, 
30, 55). 
The question of whether to supplement calcium intake is 
frequently posed to health professionals by women of all 
ages. Calcium supplements are readily available, and the 
message that dietary or supplemental calcium may improve 
one's chances of avoiding osteoporosis has been well covered 
by the media. None of the sources of calcium were 
significant factors in this study. The mean intake of 
calcium in this study was higher than that of the two 
National Health and Nutrition Examination Surveys (1000 vs 
500 mg/day) for women age 50 and older. Several 
investigators have found the food frequency to be the method 
of choice for a questionnaire or when assessing one nutrient 
in the diet (105, 106, 107). Food frequency questionnaires 
can be used to determine habitual intake and are especially 
applicable in relating diet to long-term effects (107) . They 
are low in cost as no specialized training or equipment is 
needed to administer them. This method is limited due to 
difficulty in validation, as they cover longer periods of 
time than food diaries or recall methods ( 105) . Food 
frequencies may overestimate actual intake (106, 107), and 
this may explain in part the high calcium intake calculated 
in this study. Current calcium intake may not correlate well 
with fracture risk, and previous intake can be difficult to 
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obtain with any accuracy. Our participants were free-living 
adults who may have changed their eating patterns with aging. 
Diets often simplify as family size decreases, or with the 
death of a spouse. Economic status may change with 
retirement, and physical ailments may increase . These can 
all affect food choices and preparation. We attempted to 
evaluate the usual intake of calcium, which included listing 
foods high in calcium as well as frequently eaten foods 
(cottage cheese, bread, milk in coffee) that contribute to 
the overall calcium content of the diet. Bone health as well 
as bone fragility is a complex issue, of which calcium is 
just a part. Calcium may exert more influence on peak bone 
mass achieved in youth than loss of bone mass in old age 
(108). Current bone health is the result of diet and 
lifestyle events that occurred decades earlier; therefore, 
the link of current nutritional practices to osteoporosis is 
difficult to establish. 
Summary and Recommendations 
The participants in this study were evaluated by mailout 
questionnaire, and their dietary, physical, and demographic 
characteristics were related to the incidence of osteoporotic 
fracture. Age, race, arthritis, cortisone use, and 
fluoridation of water were significantly related to the 
probability of having osteoporosis . 
Very few differences were found between the two female 
populations studied. The Utah population exercised more and 
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consumed less caffeine than the non- Utah population; however, 
these factors were not significantly related to the 
occurrence of osteoporosis in this study. 
There were certain limitations of this study which may 
have affected the outcome. This was not a random sample of 
elderly postmenopausal women. The participants represented 
the population most likely to participate at senior citizen 
centers. Although the racial demographics were similar to 
the general population, some groups such as Native Americans 
and Blacks were underrepresented and may indicate lack of 
participation at these centers . The segment of the 
population with severe or debilitating osteoporosis or other 
impairments were underrepresented, as most of these potential 
participants are either housebound to some extent , or are in 
long-term care facilities . 
The return rate of this survey was acceptable; however , 
the non-respondents may have altered the results if they had 
chosen to participate . 
Verification of the presence of osteoporosis by 
quantified computer tomography would enhance the use of this 
questionnaire . 
Treatment and prevention of osteoporosis is advancing, 
but still needs improvement. Research needs to be done to 
evaluate the interaction among risk factors such as age, 
race, arthritis, and medications . This study indicates that 
treatments for other conditions, such as arthritis, may 
increase the risk for osteoporosis. We may need to further 
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evaluate the therapeutic dosage of drugs and nutrients, such 
as cortisone and fluoride, as well as others, to improve the 
risk relationship between them and osteoporosis . 
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Appendix A 
Questionnaire used in collecting data for this study . 
F1RST, WE WOULD LIKE YOU TO ANSWER A FEW QUESTIONS ABOUT 
OSTEOPO~OSIS, BONE LOSS AND YOUR LIFESITLE. 
1. Have you ever been told by a doctor that you have osteoporosis? 
(circle number) 
l.NO 
2. 'YES 
2. Do you know if your mother had osteoporosis? 
.) , 
(circle number) 
LNO 
2. YES 
3. DO NOT KNOW 
Have you ever had any fractured or broken bones as an adult? 
(circl.e number) 
l. NO ( If NO, go to question 4) 
2. YES 
L3a. If YES, where was the fracture or broken bone and how old 
were you at the time? (circle all that apply) 
1. IDP 
2. WRIST or FOREARM 
3. SPINE 
4. OTHER(S) (please state body location) 
4 . Some people take vitamin and/or mineral supplements. Please 
check the supplements you use, give the brand name if you know it, and 
how ofren you use them. 
Suoplement Brand Name Dailv Weeklv Monthlv 
Calcium 
Vitamin D 
Fluoride 
Vitamin A 
Multi-Vitamin/ 
Mineral Tablet 
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:NEXT, WE WOULD LIKE TO ASK ABOUf YOUR DIET AND EATING HABITS. 
5. How often do you drink milk? (circle number) 
1. NEVER 
2. MONTHLY (1 to 3 days a month) 
3. WEEKLY (1 to 4 days a week) 
4. DAILY (5 to 7 days a week) 
~a. If you drink milk DAILY, how many cups (8 ounces) do 
you usually have? 
____ CUPSEACHDAY 
6. How often do you eat yogurt? (circle number) 
1. NEVER 
2. MONTHLY (1 to 3 days a month) 
3. WEEKLY (1 to 4 days a week) 1· DAILY (5 to 7 days a week) 
~6a. If you eat yogurt DAILY, how many cartons G6-8 ounces) do 
you usually have? 
____ CARTONS EACH DAY 
7. How often do you eat hard cheeses, such as Cheddar, Colby or 
American? (circle number) 
1. NEVER 
2. MONTHLY (1 . to 3 days a month) 
3. WEEKLY (1 to 4 days a week) 
(· DAILY (5 to 7 days a week) 
L 7a. If you eat cheese DAILY, how many thin slices (1 ounce) do 
you usually eat? 
____ SLICES EACH DAY 
8. How often do you eat cottage cheese? 
1. 1\TEVER 
2. MONTHLY (1 to 3 days a month) 
3. WEEKLY (1 to 4 days a week) 
4. DAILY (5 to 7 days a week) 
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8a. If you eat cottage cheese DAll.. Y, how many {1/2 cup) 
servings do you usually have? 
_____ SERVINGS EACH DAY 
9. How often do you you eat ice cream or frozen yogurt? 
1. NEVER 
2. MONTHLY (l ro 3 days a month) 
3. WEEKLY (1 to 4 days a week) 
4. DAILY (5 to 7 days a week) 
L9a. If you eat ice cream or frozen yogurt DAILY. how many 
scoops (l/2 cup) do you usually have? 
______ SCOOPS EACH DAY 
10. How many slices of bread (any kind) do you usually eat each 
day? 
____ SLICES EACH DAY 
11 . How many times each week do you eat cereal WITH MILK? 
____ TIMES EACH WEEK 
12. Please tell us how much and how often you drink the following 
beverages: (If you drink none of these, go to question 14) 
BEVERAGE DAll.. Y WEEK.L Y MONTHLY NEVER (./) 
Example: 
TEA 2 CUDS 
COFFEE 
TEA 
COLA BEVERAGES 
ALCOHOL 
13. Do you take milk (not cream or other substitute) m your coffee or 
tea? (circle number) 
I. NO 
2. YES 
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14. Do you drink fl•Jo:idated water? (cir::le n~mber) 
l.NO 
2. YES 
3. DO NOT KNOW 
NOW WE WOULD LIKE YOU TO GIVE US SOME INFORMATION ABOUT 
YOUR MEDICAL HISTORY. 
15. Please indicate if you regularly take or have taken any of the 
following medication: (circle all that .apply) 
1. DnJRETICS (Water pills or blood pressure pills) 
2. CORTISONE (Prednisone or Cortisol) 
3. ISONIAZID (For treatment of tuberculosis) 
4. ANTICONVULSANT$ (Dilantin, Phenobarbital or Mysoline) 
5 . COUMADL"-1 (Anticoagulant or blood thinner) 
6. TIIYROID .MEDICINE 
16. Please circle any of the following antacids you take regularly (more 
than once a week). 
I . TUMS 
2. ROLAIDS 
3.MAALOX 
4. MYLANTA 
5.AMPHOGEL 
6. GELUSIL 
7 . OTHER (please state name brand) __________ _ 
17. Do you smoke cigarettes? (circle number) 
1. NO (If NO, go to question 18) 
2. YES 
L17a. If YES, how much do you smoke? (circle number) 
1. LESS THAN 1/2 PACK A DAY 
2. 1/2 TO 1 PACK A DAY 
3. 1 I/2 TO 2 PACKS A DAY 
4. MORE THAN 2 PACKS A DAY 
17b. How long have you smoked? 
_____ YEARS 
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18 De yot= have · any of the following: (circle all that apply) 
1. KIDNEY DISEASE 
2. ARTHRITIS 
3 . .MILK ALLERGY OR LACfOSE ll\l"fOLERANCE 
19. Please list any surgeries you have had: 
20. How many pregnancies have you had? 
21. How many of your children did you breastfeed? 
________ CHILDREN 
L21a. If you breastfed any of your children, on the average 
how long did you breastfeed? 
__ ___,._MONTHS 
22. Have you experienced menopause? (circle number) 
1. NO (If NO, go to question 23) 
2. YES 
L22a. If YES, about how old were you at menopause? 
_____ YEARS 
22b. Do you use estrogen (hormone) replacement therapy? 
(circle number) 
1. NO 
2. YES 
23 . Have. you had a hysterectomy? (circle number) 
1. NO (If NO, go to question 24) 
2. YES 
L23a. If YES, how old were you when you had the hystectomy? 
_____ YEARS 
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24. Please circle any of the following activities you do. Tell us how 
many times a week or month you do the activity and about how 
many minutes you usually spend doing them. Do not include 
housework or gardening. 
ACriVITY WEEKLY MONTHLY # MINUTES 
EXAMPLE: 
WALKING 5 rimes 20 minutes 
1. SWIMMING 
2. JOGGWG 
3. WALKING 
4. EXERCISE BIKE/ OR 
BICYCLWG 
5. SKIING/NORDIC TRACK 
6. ROWING/ROWING MACI-llNE 
7. AEROBICS CLASS 
8. SQUARE DANCING 
9. OTHER: 
FINALLY, WE WOULD LIKE TO ASK A FEW QUESTIONS ABOUT YOURSELF 
FOR STATISTICAL PURPOSES. 
25 . What is your age? 
____ YEARS 
26. What 1s your weight? 
____ POUNDS 
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27 How tall are you? 
___ FEET __ INCHES 
28. How tall were you at age 21? 
___ FEET __ INCHES 
29. What city/town do you live in? --------
30. How long have you lived there? 
___ YEARS 
31. If less than 5 years, where did you live previously? 
CITY ________ STATE --------
32. Is your race or ethnic origin : (circle number) 
1. CAUCASION/WHITE 
2. BLACK 
S. LATIN, SPANISH OR MEXICAN AMERICAN 
4. AMERICAN INDIAN 
5. ASIAN/PACIFIC ISLANDER 
6. OTHER: -------------
33. Do you have a religious preference? (circle number) 
l.NO 
2. YES 
L33a. If YES, whin? (circle number) 
1. PROTESTANT 
2.CATHOLIC 
3. LDS 4. OTHER: _______________ __ 
YOUR TIME AND EFFORT ON THIS SURVEY IS GREATLY APPRECIATED. 
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Appendix B 
Coding of questionnaire responses used in computer entry. 
Question Item Code Response Frequency 
Abbreviation 
0 IDNUM 1000-
1600 UTAH 381 
2000-
2200 COLORADO 52 
3000-
3200 NORTH DAKOTA 119 
4000-
4200 SOUTH DAKOTA 103 
1 DR 1 NO 560 
2 YES 89 
8 OTHER 0 
9 NO RESPONSE 6 
2 HX 1 NO 583 
2 YES 65 
3 DON'T KNOW 0 
8 OTHER 0 
9 NO RESPONSE 0 
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3 FRACTURE 1 NO 420 
2 YES 270 
8 OTHER 0 
9 NO RESPONSE 25 
3A1 HIP 1 NO 647 
2 YES 40 
9 NO RESPONSE 28 
3A2 AGE HIP 00 NO FRACTURE 
* -
01-98 AGE 
99 NO RESPONSE 
3A3 WRIST 1 NO 582 
2 YES 105 
9 NO RESPONSE 28 
3A4 AGEWRIST 00 NO FRACTURE 
* 
01-98 AGE 
99 NO RESPONSE 
3A5 SPINE 1 NO 662 
2 YES 25 
9 NO RESPONSE 28 
3A6 AGESPINE 00 NO FRACTURE 
* 
01-98 AGE 
99 NO RESPONSE 
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3A7 OTHERFRC 1 NO 520 
2 YES 167 
9 NO RESPONSE 28 
3A8 AGEOTHER 00 NO FRACTURE * 
01-98 AGE 
99 NO RESPONSE 
4A CALCIUM 1 NO 393 
2 YES 262 
9 NO RESPONSE 0 
4B CA OFTEN 0 NEVER * 
-
1 DAILY 
2 WEEKLY 
3 MONTHLY 
8 OTHER 
9 NO RESPONSE 
4C VIT D 1 NO 572 
-
2 YES 83 
9 NO RESPONSE 0 
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4D D OFTEN 0 NEVER * 
-
1 DAILY 
2 WEEKLY 
3 MONTHLY 
8 OTHER 
9 NO RESPONSE 
4E FLUORIDE 1 NO 690 
2 YES 16 
9 NO RESPONSE 9 
4F FL OFTEN 0 NEVER * 
-
1 DAILY 
2 WEEKLY 
3 MONTHLY 
8 OTHER 
9 NO RESPONSE 
4G VIT A 1 NO 601 
-
2 YES 54 
9 NO RESPONSE 0 
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4H A OFTEN 0 NEVER * 
-
1 DAILY 
2 WEEKLY 
3 MONTHLY 
8 OTHER 
9 NO RESPONSE 
4I MULTI 1 NO 429 
2 YES 226 
9 NO RESPONSE 0 
4J M OFTEN 0 NEVER * 
-
1 DAILY 
2 WEEKLY 
3 MONTHLY 
8 OTHER 
9 NO RESPONSE 
5 MILK 1 NEVER 102 
2 MONTHLY 61 
3 WEEKLY 82 
4 DAILY 398 
9 NO RESPONSE 12 
SA MILK CUPS 00-09 CUPS * 
99 NO RESPONSE 
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6 YOGURT 1 NEVER 305 
2 MONTHLY 196 
3 WEEKLY 107 
4 DAILY 22 
9 NO RESPONSE 25 
6A YOGCARTS 00-09 CARTONS * 
99 NO RESPONSE 
7 CHEESE 1 NEVER 78 
2 MONTHLY 262 
3 WEEKLY 267 
4 DAILY 36 
9 NO RESPONSE 12 
7A CHEESESL 00-09 SLICES * 
99 NO RESPONSE 
8 COT CH 1 NEVER 68 
-
2 MONTHLY 366 
3 WEEKLY 190 
4 DAILY 18 
9 NO RESPONSE 13 
SA COT CHSV 00-09 SERVINGS * 
-
99 NO RESPONSE 
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9 ICE CR 1 NEVER 68 
-
2 MONTHLY 307 
3 WEEKLY 215 
4 DAILY 40 
9 NO RESPONSE 25 
9A ICE CRSC 00-09 SCOOPS * 
-
99 NO RESPONSE 
10 BREAD 00-98 SLICES * 
99 NO RESPONSE 
11 CEREAL 0-7 TIMES/WEEK * 
9 NO RESPONSE 
12A COFFEE 1 NO 220 
2 YES 423 
9 NO RESPONSE 12 
12B COFOFTEN 0 NEVER 220 
1 DAILY 402 
2 WEEKLY 13 
3 MONTHLY 8 
9 NO RESPONSE 12 
12C COF CUPS 00-98 CUPS * 
-
99 NO RESPONSE 
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12D TEA 1 NO 456 
2 YES 185 
9 NO RESPONSE 14 
12E TEA OFTEN 0 NEVER 456 
1 DAILY 113 
2 WEEKLY 47 
3 MONTHLY 25 
9 NO RESPONSE 14 
12F TEA CUPS 00-98 CUPS * 
-
99 NO RESPONSE 
12G COLA 1 NO 398 
2 YES 244 
9 NO RESPONSE 13 
12H COLOFTEN 0 NEVER 398 
1 DAILY 113 
2 WEEKLY 90 
3 MONTHLY 41 
9 NO RESPONSE 13 
12I COLA CAN 00-98 12 OUNCE CAN * 
-
99 NO RESPONSE 
12J ALCOHOL 1 NO 588 
2 YES 62 
9 NO RESPONSE 3 
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12K ALCOFTEN 0 NEVER 588 
1 DAILY 5 
2 WEEKLY 48 
3 MONTHLY 9 
9 NO RESPONSE 5 
12L ALC SV 1-8 SERVINGS * 
-
9 NO RESPONSE 
13 MILKCOF 1 NO * 
2 YES 
9 NO RESPONSE 
14 FLH20 1 NO 281 
2 YES 206 
3 DON'T KNOW 138 
9 NO RESPONSE 30 
15.1 DIURETIC 1 NO 348 
2 YES 303 
9 NO RESPONSE 4 
15.2 CORTISONE 1 NO 595 
2 YES 56 
9 NO RESPONSE 4 
15.3 ISON 1 NO 707 
2 YES 3 
9 NO RESPONSE 5 
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15.4 ANTI CON 1 NO 702 
2 YES 8 
9 NO RESPONSE 5 
15.5 COUMADIN 1 NO 608 
2 YES 43 
9 NO RESPONSE 4 
15.6 THYROID 1 NO 543 
2 YES 108 
9 NO RESPONSE 4 
16.1 TUMS 1 NO 556 
2 YES 95 
9 NO RESPONSE 4 
16.2 ROLAIDS 1 NO 661 
2 YES 49 
9 NO RESPONSE 5 
16.3 MAALOX 1 NO 674 
2 YES 36 
9 NO RESPONSE 5 
16.4 MYLANTA 1 NO 660 
2 YES 50 
9 NO RESPONSE 5 
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16.5 AMPHOGEL 1 NO 708 
2 YES 2 
9 NO RESPONSE 5 
16.6 GELUSIL 1 NO 704 
2 YES 6 
9 NO RESPONSE 5 
16.7 OTHERANT 1 NO 662 
2 YES 48 
9 NO RESPONSE 5 
17 CIG 1 NO 594 
2 YES 44 
8 OTHER 0 
9 NO RESPONSE 21 
17A CIG AMT 0 NONE * 
-
1 <.5 PACK/DAY 
2 .5-1 
3 PACK/DAY 
-
4 1. 5-2 
9 PACKS/DAY 
>2 PACKS/DAY 
NO RESPONSE 
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17B YR SMOKE 00 NONE 
* -
01-98 YEARS 
99 NO RESPONSE 
18.1 KIDNEY 1 NO 682 
2 YES 16 
9 NO RESPONSE 17 
18.2 ARTHRIT 1 NO 301 
2 YES 342 
9 NO RESPONSE 12 
18.3 LACTOSE 1 NO 597 
2 YES 46 
9 NO RESPONSE 12 
19 SURG INT 1 NO 678 
-
2 YES 20 
9 NO RESPONSE 17 
20 PREG 00-98 PREGNANCIES 
* 
99 NO RESPONSE 
21 BF 00-98 CHILDREN 
* 
99 NO RESPONSE 
21A BF MONTH 00-98 MONTHS 
* -
99 NO RESPONSE 
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22 MENOPAUS 1 NO 0 
2 YES 485 
9 NO RESPONSE 170 
22A AGE MENO 00-98 YEARS * 
-
99 NO RESPONSE 
22B ESTROGEN 1 NO 446 
2 YES 118 
8 OTHER 0 
9 NO RESPONSE 91 
23 HYSTEREC 1 NO 340 
2 YES 270 
9 NO RESPONSE 45 
23A AGE HYST 00-98 YEARS * 
-
99 NO RESPONSE 
24A SWIM 1 NO 664 
2 YES 31 
9 NO RESPONSE 20 
24B SWIMXMO 00-98 TIMES/MONTH * 
99 NO RESPONSE 
24C SWIM MIN 0000- MINUTES * 
-
9998 NO RESPONSE 
9999 
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240 JOG 1 NO 640 
2 YES 2 
9 NO RESPONSE 13 
24E JOGXMON 00-98 TIMES/MONTH * 
99 NO RESPONSE 
24F JOG MIN 0000- MINUTES * 
-
9998 NO RESPONSE 
9999 
24G WALK 1 NO 192 
2 YES 450 
9 NO RESPONSE 13 
24H WALKXMON 00-98 TIMES/MONTH * 
99 NO RESPONSE 
24I WALK MIN 0000- MINUTES * 
-
9998 NO RESPONSE 
9999 
24J BIKE 1 NO 523 
2 YES 119 
9 NO RESPONSE 13 
24K BIKEXMON 00-98 TIMES/MONTH * 
99 NO RESPONSE 
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24L BIKE MIN 0000- MINUTES * 
-
9998 NO RESPONSE 
9999 
24M SKI 1 NO 635 
2 YES 7 
9 NO RESPONSE 13 
24N SKIXMON 00-98 TIMES/MONTH * 
99 NO RESPONSE 
240 SKI MIN 0000- MINUTES * 
-
9998 NO RESPONSE 
9999 
24P ROW 1 NO 635 
2 YES 7 
9 NO RESPONSE 13 
24Q ROWXMON 00-98 TIMES/MONTH * 
99 NO RESPONSE 
24R ROW MIN 0000- MINUTES * 
-
9998 NO RESPONSE 
9999 
24S AEROBICS 1 NO 610 
2 YES 32 
9 NO RESPONSE 13 
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24T AEROXMON 00-98 TIMES/MONTH * 
99 NO RESPONSE 
24U AERO MIN 0000- MINUTES * 
-
9998 NO RESPONSE 
9999 
24V DANCE 1 NO 633 
2 YES 9 
9 NO RESPONSE 13 
24W DANCXMON 00-98 TIMES/MONTH * 
99 NO RESPONSE 
24X DANC MIN 0000- MINUTES * 
-
9998 NO RESPONSE 
9999 
24Y OTHER EX 1 NO 594 
-
2 YES 101 
9 NO RESPONSE 20 
24Z OTHERXMO 00-98 TIMES/MONTH * 
99 NO RESPONSE 
24AA OTHR MIN 0000- MINUTES * 
-
9998 NO RESPONSE 
9999 
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25 AGE 00-98 YEARS * 
99 NO RESPONSE 
26 WT 000- POUNDS * 
998 NO RESPONSE 
999 
27 HT oo.o- INCHES * 
99.8 NO RESPONSE 
99.9 
28 HT 21 00.0- INCHES * 
-
99.8 NO RESPONSE 
99 . 9 
29 YRSLIVED 00-98 YEARS * 
99 NO RESPONSE 
30 PREV ST 00-51 STATE * 
-
99 NO RESPONSE 
31 RACE 1 CAUCASIAN 594 
2 BLACK 14 
3 MEXICAN 0 
4 AMERICAN 
5 INDIAN 0 
6 ASIAN 23 
9 OTHER 0 
NO RESPONSE 24 
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32 REL PREF 1 NO 37 
-
2 YES 609 
9 NO RESPONSE 9 
32A RELIGION 0 NONE 37 
1 PROTESTANT 245 
2 CATHOLIC 90 
3 LDS 255 
4 OTHER 19 
9 NO RESPONSE 9 
*Either non-categorical data or not used in analysis. 
